Holmes W E, Angel T E, Li K W, Hellerstein M K
KineMed Inc., Emeryville, California, USA.
KineMed Inc., Emeryville, California, USA; Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, California, USA.
Methods Enzymol. 2015;561:219-76. doi: 10.1016/bs.mie.2015.05.018. Epub 2015 Jul 17.
Control of biosynthetic and catabolic rates of polymers, including proteins, stands at the center of phenotype, physiologic adaptation, and disease pathogenesis. Advances in stable isotope-labeling concepts and mass spectrometric instrumentation now allow accurate in vivo measurement of protein synthesis and turnover rates, both for targeted proteins and for unbiased screening across the proteome. We describe here the underlying principles and operational protocols for measuring protein dynamics, focusing on metabolic labeling with (2)H2O (heavy water) combined with tandem mass spectrometric analysis of mass isotopomer abundances in trypsin-generated peptides. The core principles of combinatorial analysis (mass isotopomer distribution analysis or MIDA) are reviewed in detail, including practical advantages, limitations, and technical procedures to ensure optimal kinetic results. Technical factors include heavy water labeling protocols, optimal duration of labeling, clean up and simplification of sample matrices, accurate quantitation of mass isotopomer abundances in peptides, criteria for adequacy of mass spectrometric abundance measurements, and calculation algorithms. Some applications are described, including the noninvasive "virtual biopsy" strategy for measuring molecular flux rates in tissues through measurements in body fluids. In addition, application of heavy water labeling to measure flux lipidomics is noted. In summary, the combination of stable isotope labeling, particularly from (2)H2O, with tandem mass spectrometric analysis of mass isotopomer abundances in peptides, provides a powerful approach for characterizing the dynamics of proteins across the global proteome. Many applications in research and clinical medicine have been achieved and many others can be envisioned.
对包括蛋白质在内的聚合物生物合成和分解代谢速率的控制,是表型、生理适应和疾病发病机制的核心。稳定同位素标记概念和质谱仪器的进展,现在使得能够在体内准确测量靶向蛋白质以及对蛋白质组进行无偏筛选时的蛋白质合成和周转率。我们在此描述测量蛋白质动态的基本原理和操作方案,重点是用(2)H2O(重水)进行代谢标记,并结合对胰蛋白酶生成肽段中质量同位素异构体丰度的串联质谱分析。详细回顾了组合分析(质量同位素异构体分布分析或MIDA)的核心原理,包括实际优势、局限性以及确保获得最佳动力学结果的技术程序。技术因素包括重水标记方案、最佳标记持续时间、样品基质的清理和简化、肽段中质量同位素异构体丰度的准确定量、质谱丰度测量充分性的标准以及计算算法。描述了一些应用,包括通过对体液的测量来测量组织中分子通量率的非侵入性“虚拟活检”策略。此外,还提到了重水标记在测量通量脂质组学中的应用。总之,稳定同位素标记,特别是来自(2)H2O的标记,与对肽段中质量同位素异构体丰度的串联质谱分析相结合,为表征全球蛋白质组中蛋白质的动态提供了一种强大的方法。在研究和临床医学中已经实现了许多应用,并且还可以设想许多其他应用。